Bayer Schering Pharma Ag

Schering Aktiengessellschaft

Kumar Emayan

Raju Mohan

Brad Owen Buckman

Shendong Yuan

Imadul Islam

Judi Bryant

Karen B May

Christopher West

Compounds of the following formula (I), for example: wherein R, R, R, and Rare described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.

Plasma carboxypeptidase B inhibitors

Compounds of the following formula (I), for example: (1), wherein R, R, R, and Rare described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein. 

Growing community of inventors

Berkeley, CA, United States of America

Kumar Emayan